Yuri Aleksander-Ivanov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuri Aleksander-Ivanov has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Lidia Cheidde
Faculty of Medicine, Pontifical Catholic University of Sao Paulo (PUC-SP), Sorocaba, São Paulo, Brazil
3 shared publications- Dillan Cunha Amaral
Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
2 shared publications Luiz Alberto Zago Filho
Department of Ophthalmology and Otorhinolaryngology, Federal University of Parana, Curitiba, Brazil; and
2 shared publications- Ricardo Noguera Louzada
Department of Ophthalmology and Otorhinolaryngology, Faculty of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
2 shared publications - Alexandra Ioppi Zugno
Translational Psychiatry Laboratory, Graduate Program in Health Sciences, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil
1 shared publication - Alexandre Yamada Fujimura Júnior
Division of Medicine, Marilia medical school, São Paulo, Brazil
1 shared publication
Latest Publications
- 27 July 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 52 (12) , 1247-1254
Absorbable, nonabsorbable, and sutureless wound closure in pediatric cataract surgery: systematic review and meta-analysis
Topic: To compare postoperative outcomes of absorbable vs nonabsorbable sutures and sutureless vs sutured incisions in pediatric cataract surgery (0 to 18 years). Clinical Relevance: Pediatric cataract surgery requires precise wound closure to ensure postoperative stability. Identifying the most effective closure method is essential to minimize complications and the need for reintervention under general anesthesia. Methods: The review protocol was registered in the International Prospective Register of Systematic Reviews (CRD420251174549). We searched PubMed, Embase, Cochrane, and Web of Science (inception to October 2025). The primary outcome was the overall rate of postoperative complications. Meta-analysis used the Mantel-Haenszel fixed-effects model (Review Manager 5.4); certainty of evidence was assessed through Grading of Recommendations Assessment, Development, and Evaluation. Results: 8 studies (4 per comparison) evaluated suture material (321 absorbable and 430 nonabsorbable) and closure technique (1127 sutureless and 187 sutured closure). Absorbable sutures were associated with significantly lower odds of overall complications than nonabsorbable sutures (odds ratio [OR] 2.35; 95% CI 1.38-3.99; P = .002; very low–certainty evidence). Specifically, 10-0 polyglactin 910 outperformed 10-0 nylon (OR 2.18; P = .005; very low–certainty evidence), although loosening was more frequent ( P = .05). Sutureless closure was associated with significantly lower complication odds than sutured techniques (OR 0.34; 95% CI 0.23-0.49; P < .00001; very low–certainty evidence). No significant differences were found for wound leakage ( P = .60) or endophthalmitis ( P = .10). Conclusions: Absorbable sutures and sutureless techniques are associated with a lower risk of overall complications. However, results are limited by very low–certainty and potential selection bias because sutures are often reserved for leaking wounds. Although nonabsorbable sutures provide early wound security, they seem to increase long-term ocular surface morbidity. Large scale randomized controlled trials are required to establish definitive surgical guidelines.
- 27 July 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 52 (12) , 1247-1254
Absorbable, nonabsorbable, and sutureless wound closure in pediatric cataract surgery: systematic review and meta-analysis
Topic: To compare postoperative outcomes of absorbable vs nonabsorbable sutures and sutureless vs sutured incisions in pediatric cataract surgery (0 to 18 years). Clinical Relevance: Pediatric cataract surgery requires precise wound closure to ensure postoperative stability. Identifying the most effective closure method is essential to minimize complications and the need for reintervention under general anesthesia. Methods: The review protocol was registered in the International Prospective Register of Systematic Reviews (CRD420251174549). We searched PubMed, Embase, Cochrane, and Web of Science (inception to October 2025). The primary outcome was the overall rate of postoperative complications. Meta-analysis used the Mantel-Haenszel fixed-effects model (Review Manager 5.4); certainty of evidence was assessed through Grading of Recommendations Assessment, Development, and Evaluation. Results: 8 studies (4 per comparison) evaluated suture material (321 absorbable and 430 nonabsorbable) and closure technique (1127 sutureless and 187 sutured closure). Absorbable sutures were associated with significantly lower odds of overall complications than nonabsorbable sutures (odds ratio [OR] 2.35; 95% CI 1.38-3.99; P = .002; very low–certainty evidence). Specifically, 10-0 polyglactin 910 outperformed 10-0 nylon (OR 2.18; P = .005; very low–certainty evidence), although loosening was more frequent ( P = .05). Sutureless closure was associated with significantly lower complication odds than sutured techniques (OR 0.34; 95% CI 0.23-0.49; P < .00001; very low–certainty evidence). No significant differences were found for wound leakage ( P = .60) or endophthalmitis ( P = .10). Conclusions: Absorbable sutures and sutureless techniques are associated with a lower risk of overall complications. However, results are limited by very low–certainty and potential selection bias because sutures are often reserved for leaking wounds. Although nonabsorbable sutures provide early wound security, they seem to increase long-term ocular surface morbidity. Large scale randomized controlled trials are required to establish definitive surgical guidelines.
- 24 July 2026
- Published by SAGE Publications in European Journal of Ophthalmology
Risk factors for graves’ orbitopathy: A systematic review and meta-analysis
Introduction: Understanding the modifiable risk factors for Graves’ orbitopathy (GO) is crucial for its prevention. Methods: We searched PubMed, Embase, and Web of Science databases following PRISMA guidelines. Studies reporting the presence of GO compared to patients with Graves’ disease (GD) without orbitopathy or healthy controls were included. Statistical analysis was performed using Review Manager 5.4.1. Results: Twenty-two studies met the inclusion criteria. Smoking increased the risk of GO, with odds ratios (ORs) of 2.00 (95% CI [1.47, 2.72]; p < 0.0001) for current smokers and 1.77 (95% CI [1.33, 2.37]; p = 0.0001) for former smokers, compared with GD patients without orbitopathy. Thyroidectomy was associated with a higher OR of Graves’ disease without orbitopathy, supporting a protective effect against orbitopathy (OR 2.53; 95% CI [1.03, 6.22]; p = 0.04). However, radioiodine therapy did not show a significant association (OR 0.89; 95% CI [0.42, 1.91]; p = 0.77). Biomarkers, including vitamin D ( p = 0.63), FT3 ( p = 0.89), FT4 ( p = 0.59), and TSH ( p = 0.40), showed no significant differences. In comparison to healthy controls, smoking remained a major risk factor for GO (OR 4.81; 95% CI [1.39, 16.70]; p = 0.01), while elevated FT4 (MD 8.87; 95% CI [1.64, 16.10]; p = 0.02) and decreased TSH (MD −1.23; 95% CI [-2.25, −0.20]; p = 0.02) levels were found in the GO groups. Conclusion: Our analysis provides a comprehensive understanding of clinical and biomarker-based risk factors to guide targeted prevention strategies.
- 24 July 2026
- Published by SAGE Publications in European Journal of Ophthalmology
Risk factors for graves’ orbitopathy: A systematic review and meta-analysis
Introduction: Understanding the modifiable risk factors for Graves’ orbitopathy (GO) is crucial for its prevention. Methods: We searched PubMed, Embase, and Web of Science databases following PRISMA guidelines. Studies reporting the presence of GO compared to patients with Graves’ disease (GD) without orbitopathy or healthy controls were included. Statistical analysis was performed using Review Manager 5.4.1. Results: Twenty-two studies met the inclusion criteria. Smoking increased the risk of GO, with odds ratios (ORs) of 2.00 (95% CI [1.47, 2.72]; p < 0.0001) for current smokers and 1.77 (95% CI [1.33, 2.37]; p = 0.0001) for former smokers, compared with GD patients without orbitopathy. Thyroidectomy was associated with a higher OR of Graves’ disease without orbitopathy, supporting a protective effect against orbitopathy (OR 2.53; 95% CI [1.03, 6.22]; p = 0.04). However, radioiodine therapy did not show a significant association (OR 0.89; 95% CI [0.42, 1.91]; p = 0.77). Biomarkers, including vitamin D ( p = 0.63), FT3 ( p = 0.89), FT4 ( p = 0.59), and TSH ( p = 0.40), showed no significant differences. In comparison to healthy controls, smoking remained a major risk factor for GO (OR 4.81; 95% CI [1.39, 16.70]; p = 0.01), while elevated FT4 (MD 8.87; 95% CI [1.64, 16.10]; p = 0.02) and decreased TSH (MD −1.23; 95% CI [-2.25, −0.20]; p = 0.02) levels were found in the GO groups. Conclusion: Our analysis provides a comprehensive understanding of clinical and biomarker-based risk factors to guide targeted prevention strategies.
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-16
The Acute Effects of Caffeine on OCT and OCTA Parameters: A Systematic Review and Meta-Analysis
Purpose: This systematic review and meta-analysis aimed to comprehensively assess the acute effects of caffeine and caffeinated beverages on ocular microvasculature measured by optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) parameters, explicitly focusing on subfoveal choroidal thickness (SFCT) and superficial capillary vessel density (SVD), and deep capillary vessel density (DVD). Methods: A systematic search was conducted across PubMed, the Cochrane Database, and Embase for trials evaluating the acute effects of caffeine or caffeinated beverages on SFCT, SVD, and DVD, as measured by OCTA. Pooled mean differences (MD) were calculated using random-effects models, with heterogeneity assessed by I2 statistics. Subgroup analyses were performed by study design, intervention type, and refractive status. The protocol was prospectively registered in PROSPERO (CRD420251091123). Statistical analyses were performed using RStudio 2025.05.1+513. Results: 18 studies comprising 630 patients were included. Pooled analysis demonstrated a significant reduction in SFCT after caffeine intake (– 23.79 μm; 95% CI: – 31.43 to – 16.15; p < 0.001), particularly with coffee and caffeine capsules, whereas no effect was observed with energy drinks or in highly myopic eyes. Regarding SVD, caffeine was associated with significant reductions across foveal, parafoveal, and perifoveal regions, mainly driven by coffee and capsule interventions. In DVD analyses, no overall significant effect was found; however, subgroup analyses indicated significant reductions with caffeine capsules and coffee, while energy drinks showed opposite trends. Conclusion: Acute caffeine intake, primarily from capsules or coffee, induces significant SFCT reduction and modest reductions in SVD, while changes in DVD were confined mainly to the caffeine-capsule subgroup, suggesting that energy drink ingredients may counteract caffeine-induced vasoconstriction. These findings offer valuable insights into the acute effects of caffeine on ocular microvasculature; however, the modest effect sizes necessitate caution regarding inherent physiological, measurement, and bioactive components variability. This study establishes a foundation for future investigations into the clinical significance of acute ocular microvascular fluctuations following caffeine intake.
- 1 April 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-16
Open AccessThe Acute Effects of Caffeine on OCT and OCTA Parameters: A Systematic Review and Meta-Analysis
Purpose: This systematic review and meta-analysis aimed to comprehensively assess the acute effects of caffeine and caffeinated beverages on ocular microvasculature measured by optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) parameters, explicitly focusing on subfoveal choroidal thickness (SFCT) and superficial capillary vessel density (SVD), and deep capillary vessel density (DVD). Methods: A systematic search was conducted across PubMed, the Cochrane Database, and Embase for trials evaluating the acute effects of caffeine or caffeinated beverages on SFCT, SVD, and DVD, as measured by OCTA. Pooled mean differences (MD) were calculated using random-effects models, with heterogeneity assessed by I2 statistics. Subgroup analyses were performed by study design, intervention type, and refractive status. The protocol was prospectively registered in PROSPERO (CRD420251091123). Statistical analyses were performed using RStudio 2025.05.1+513. Results: 18 studies comprising 630 patients were included. Pooled analysis demonstrated a significant reduction in SFCT after caffeine intake (– 23.79 μm; 95% CI: – 31.43 to – 16.15; p < 0.001), particularly with coffee and caffeine capsules, whereas no effect was observed with energy drinks or in highly myopic eyes. Regarding SVD, caffeine was associated with significant reductions across foveal, parafoveal, and perifoveal regions, mainly driven by coffee and capsule interventions. In DVD analyses, no overall significant effect was found; however, subgroup analyses indicated significant reductions with caffeine capsules and coffee, while energy drinks showed opposite trends. Conclusion: Acute caffeine intake, primarily from capsules or coffee, induces significant SFCT reduction and modest reductions in SVD, while changes in DVD were confined mainly to the caffeine-capsule subgroup, suggesting that energy drink ingredients may counteract caffeine-induced vasoconstriction. These findings offer valuable insights into the acute effects of caffeine on ocular microvasculature; however, the modest effect sizes necessitate caution regarding inherent physiological, measurement, and bioactive components variability. This study establishes a foundation for future investigations into the clinical significance of acute ocular microvascular fluctuations following caffeine intake.
- 1 April 2026
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (4) , 575-586
ANTIBIOTIC PROPHYLAXIS FOR PREVENTING ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTIONS
Purpose: Endophthalmitis is a rare but severe complication of intravitreal injections that can result in significant vision loss. This systematic review and meta-analysis aimed to evaluate the efficacy of topical antibiotic prophylaxis in reducing endophthalmitis incidence, a topic of ongoing controversy and varied clinical practice worldwide. Methods: A systematic review and meta-analysis was conducted by searching PubMed, Embase, Cochrane, and Web of Science through July 2025. Studies comparing endophthalmitis incidence in intravitreal injections with and without antibiotic prophylaxis were included; reviews, case reports, and studies lacking outcome data were excluded. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the risk of bias in nonrandomized studies of interventions tool. Data were pooled using a random-effects model. The protocol was registered in PROSPERO (CRD420251102460). Results: Twenty-two studies encompassing 5,834,932 intravitreal injections (3,426,671 with prophylaxis and 2,408,261 without) were included. Overall, no significant difference in endophthalmitis incidence was observed between groups ( P = 0.09). However, a subgroup analysis of antivascular endothelial growth factor injections showed a significantly higher risk of endophthalmitis in the antibiotic group (odds ratio, 1.56; 95% confidence interval, 1.03–2.36; I 2 = 31%; very low-certainty evidence). Conclusion: Topical antibiotic prophylaxis was not associated with a reduced risk of endophthalmitis and may increase the risk in patients receiving antivascular endothelial growth factor intravitreal injections. These findings suggest that the routine use of antibiotic prophylaxis for these injections is unwarranted.
- 1 April 2026
- Published by Wolters Kluwer Health in Retina
- Vol. 46 (4) , 575-586
ANTIBIOTIC PROPHYLAXIS FOR PREVENTING ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTIONS
Purpose: Endophthalmitis is a rare but severe complication of intravitreal injections that can result in significant vision loss. This systematic review and meta-analysis aimed to evaluate the efficacy of topical antibiotic prophylaxis in reducing endophthalmitis incidence, a topic of ongoing controversy and varied clinical practice worldwide. Methods: A systematic review and meta-analysis was conducted by searching PubMed, Embase, Cochrane, and Web of Science through July 2025. Studies comparing endophthalmitis incidence in intravitreal injections with and without antibiotic prophylaxis were included; reviews, case reports, and studies lacking outcome data were excluded. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the risk of bias in nonrandomized studies of interventions tool. Data were pooled using a random-effects model. The protocol was registered in PROSPERO (CRD420251102460). Results: Twenty-two studies encompassing 5,834,932 intravitreal injections (3,426,671 with prophylaxis and 2,408,261 without) were included. Overall, no significant difference in endophthalmitis incidence was observed between groups ( P = 0.09). However, a subgroup analysis of antivascular endothelial growth factor injections showed a significantly higher risk of endophthalmitis in the antibiotic group (odds ratio, 1.56; 95% confidence interval, 1.03–2.36; I 2 = 31%; very low-certainty evidence). Conclusion: Topical antibiotic prophylaxis was not associated with a reduced risk of endophthalmitis and may increase the risk in patients receiving antivascular endothelial growth factor intravitreal injections. These findings suggest that the routine use of antibiotic prophylaxis for these injections is unwarranted.
- 1 May 2025
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 41 (4) , 199-209
Safety and Efficacy of 0.1% Cyclosporine Solutions in Dry Eye Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Purpose: Cyclosporine A (CsA) is a primary treatment for dry eye disease (DED). Ophthalmic solutions containing CsA are available in concentrations of 0.05%, 0.09%, and 0.1%. While 0.1% CsA solutions have been used to treat DED, their safety and effectiveness remains somewhat uncertain. Therefore, we conducted a meta-analysis to evaluate their safety and efficacy. Methods: We searched PubMed, Cochrane Database, Embase, and Web of Science for randomized controlled trials (RCTs) that compared 0.1% CsA solutions with their vehicle. Statistical analysis was performed using Review Manager 5.4.1. Results: We included six RCTs (2,170 patients) with follow-up periods ranging from 4 weeks to 6 months. A total of 1,119 patients (51.56%) with DED were treated with 0.1% CsA. The mean age of patients was 57.9 ± 4.8 years, with 79.7% being female. The total corneal fluorescein staining (tCFS) at last follow-up [mean differences (MD) -0.49; 95% confidence interval (CI) (-0.73, -0.24); P < 0.0001], at 4 weeks [MD -0.64; 95% CI (-1.07, -0.22); P = 0.003], and central corneal fluorescein staining (cCFS) [MD -0.19; 95% CI (-0.35, -0.03); P = 0.02] scores were lower in patients treated with 0.1% CsA compared with vehicle. The Lissamine Green conjunctival staining (LGCS) [MD -0.51; 95% CI (-0.78, -0.24); P = 0.0002] and ocular surface disease index (OSDI) scores [MD -3.04; 95% CI (-5.84, -0.23); P = 0.03] were lower in the 0.1% CsA group compared with vehicle. Adverse events associated with 0.1% CsA solution in the treatment of DED varied across studies, but were generally mild to moderate. Notably, similar events were also significantly present in the vehicle group, supporting the safety profile of this treatment. Conclusion: Ophthalmic 0.1% CsA seems safe for treating DED, and significantly reduced tCFS, cCFS, LGCS, and OSDI scores compared with vehicle solutions.
- 1 May 2025
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 41 (4) , 199-209
Safety and Efficacy of 0.1% Cyclosporine Solutions in Dry Eye Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Purpose: Cyclosporine A (CsA) is a primary treatment for dry eye disease (DED). Ophthalmic solutions containing CsA are available in concentrations of 0.05%, 0.09%, and 0.1%. While 0.1% CsA solutions have been used to treat DED, their safety and effectiveness remains somewhat uncertain. Therefore, we conducted a meta-analysis to evaluate their safety and efficacy. Methods: We searched PubMed, Cochrane Database, Embase, and Web of Science for randomized controlled trials (RCTs) that compared 0.1% CsA solutions with their vehicle. Statistical analysis was performed using Review Manager 5.4.1. Results: We included six RCTs (2,170 patients) with follow-up periods ranging from 4 weeks to 6 months. A total of 1,119 patients (51.56%) with DED were treated with 0.1% CsA. The mean age of patients was 57.9 ± 4.8 years, with 79.7% being female. The total corneal fluorescein staining (tCFS) at last follow-up [mean differences (MD) -0.49; 95% confidence interval (CI) (-0.73, -0.24); P < 0.0001], at 4 weeks [MD -0.64; 95% CI (-1.07, -0.22); P = 0.003], and central corneal fluorescein staining (cCFS) [MD -0.19; 95% CI (-0.35, -0.03); P = 0.02] scores were lower in patients treated with 0.1% CsA compared with vehicle. The Lissamine Green conjunctival staining (LGCS) [MD -0.51; 95% CI (-0.78, -0.24); P = 0.0002] and ocular surface disease index (OSDI) scores [MD -3.04; 95% CI (-5.84, -0.23); P = 0.03] were lower in the 0.1% CsA group compared with vehicle. Adverse events associated with 0.1% CsA solution in the treatment of DED varied across studies, but were generally mild to moderate. Notably, similar events were also significantly present in the vehicle group, supporting the safety profile of this treatment. Conclusion: Ophthalmic 0.1% CsA seems safe for treating DED, and significantly reduced tCFS, cCFS, LGCS, and OSDI scores compared with vehicle solutions.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 96 (2) , e20230367
Eating Disorder Risks Associated with Time Spent Using Social Media at an AMREC Population in the Coal Mining Region of Santa Catarina
Comparing one’s appearance to other people’s and believing in an ideal body shape can negatively impact an individual. The probability of developing ED in individuals with high body dissatisfaction is higher than in the general population, leading to long-term emotional and metabolic damage. Populational studies on the prevalence of ED in Brazil are scarce in the literature. The research was carried out through the Google Forms website and evaluated risk of eating disorders through the Eating Attitude Test, degree of body dissatisfaction in the sample through the Body Shape Questionnaire and the Internet Addiction Test was used to evaluate time spent on the internet. The results showed that 84.5% of the sample were female and 62.3% of the individuals had eutrophic by the Body Mass Index. About 40.2% of the population studied had abnormal attitudes towards food, indicating a possible risk of developing ED, and 62.5% of the sample did not show body dissatisfaction. Regarding internet use, 10.8% had problematic internet use. The presence of risky eating attitudes was more prevalent in participants dissatisfied with their bodies. In addition, participants with problematic internet use had a higher risk for EDs.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 96 (2) , e20230367
Open AccessEating Disorder Risks Associated with Time Spent Using Social Media at an AMREC Population in the Coal Mining Region of Santa Catarina
Comparing one’s appearance to other people’s and believing in an ideal body shape can negatively impact an individual. The probability of developing ED in individuals with high body dissatisfaction is higher than in the general population, leading to long-term emotional and metabolic damage. Populational studies on the prevalence of ED in Brazil are scarce in the literature. The research was carried out through the Google Forms website and evaluated risk of eating disorders through the Eating Attitude Test, degree of body dissatisfaction in the sample through the Body Shape Questionnaire and the Internet Addiction Test was used to evaluate time spent on the internet. The results showed that 84.5% of the sample were female and 62.3% of the individuals had eutrophic by the Body Mass Index. About 40.2% of the population studied had abnormal attitudes towards food, indicating a possible risk of developing ED, and 62.5% of the sample did not show body dissatisfaction. Regarding internet use, 10.8% had problematic internet use. The presence of risky eating attitudes was more prevalent in participants dissatisfied with their bodies. In addition, participants with problematic internet use had a higher risk for EDs.